Evidence map›Paper›PMID 27333343›Full record

ReviewJournal of neurochemistry2016

Synaptopathies: synaptic dysfunction in neurological disorders - A review from students to students.

Katarzyna Lepeta, Mychael V Lourenco, Barbara C Schweitzer, Pamela V Martino Adami, Priyanjalee Banerjee, Silvina Catuara-Solarz, Mario de La Fuente Revenga, Alain Marc Guillem, Mouna Haidar, Omamuyovwi M Ijomone and 15 more

Open access · bronzeAbstract readReview
In one paragraph

Review in Journal of neurochemistry, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 215 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
215citing papers in PubMed, 2 pooled it
12.7field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

215 citing papers in PubMed, 2 syntheses or guidelines pooled it, 368 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Article
  5. Article
  6. International journal of molecular sciences · 2026
    Review
  7. eLife · 2026
    Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Fully Automated Azeotropic Drying-Free Synthesis of [Molecules (Basel, Switzerland) · 2026
    Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Review
  19. Article
  20. Article

155 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

25 authors at 20 institutions in 15 countries.

Katarzyna LepetaDepartment of Molecular and Cellular Neurobiology, Nencki Institute of Experimental Biology, Polish Academy of Sciences, Warsaw, Poland.
Mychael V LourencoInstitute of Medical Biochemistry Leopoldo de Meis, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil.
Barbara C SchweitzerDepartment for Neurochemistry and Molecular Biology, Leibniz Institute for Neurobiology Magdeburg, Magdeburg, Germany.
Pamela V Martino AdamiLaboratory of Amyloidosis and Neurodegeneration, Fundación Instituto Leloir-IIBBA-CONICET, Buenos Aires, Argentina.
Priyanjalee BanerjeeDepartment of Biochemistry, Institute of Post Graduate Medical Education & Research, Kolkata, West Bengal, India.
Silvina Catuara-SolarzSystems Biology Program, Cellular and Systems Neurobiology, Centre for Genomic Regulation, The Barcelona Institute of Science and Technology, Barcelona, Spain.
Mario de La Fuente RevengaDepartment of Physiology and Biophysics, Virginia Commonwealth University, Richmond, VA, United States of America.
Alain Marc GuillemLaboratorio de Neurotoxicología, Departamento de Toxicología, Centro de Investigación y de Estudios Avanzados del Instituto Politécnico Nacional, México D.F. 07000, Mexico.
Mouna HaidarFlorey Institute of Neuroscience and Mental Health, University of Melbourne, Victoria, Australia.
Omamuyovwi M IjomoneDepartment of Human Anatomy, Cross River University of Technology, Okuku Campus, Cross River, Nigeria.
Bettina NadorpThe Department of Biological Chemistry, The Edmond and Lily Safra Center for Brain Sciences, The Alexander Grass Center for Bioengineering, The Hebrew University of Jerusalem, Israel.
Lin QiLaboratory of Molecular Neuro-Oncology, Texas Children's Hospital, Baylor College of Medicine, Houston, TX, United States of America.
Nirma D PereraFlorey Institute of Neuroscience and Mental Health, University of Melbourne, Victoria, Australia.
Louise K RefsgaardDepartment of Drug Design and Pharmacology, Faculty of Health and Medical Sciences, University of Copenhagen, Denmark.
Kimberley M ReidDepartment of Pharmacology, UCL School of Pharmacy, 29-39 Brunswick Square, London, WC1N 1AX, UK.
Mariam SabbarBrain Function Research Group, School of Physiology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
Arghyadip SahooDepartment of Biochemistry, Midnapore Medical College, West Bengal University of Health Sciences, West Bengal, India.
Natascha SchaeferInstitute for Clinical Neurobiology, Julius-Maximilians-University of Wuerzburg, Wuerzburg, Germany.
Rebecca K SheeanFlorey Institute of Neuroscience and Mental Health, University of Melbourne, Victoria, Australia.
Anna SuskaDepartment of Molecular and Cellular Neurobiology, Nencki Institute of Experimental Biology, Polish Academy of Sciences, Warsaw, Poland.
Rajkumar VermaDepartment of Neurosciences Uconn Health Center, Farmington, CT, United States of America.
Cinzia VicidominiCNR, Institute of Neuroscience, Milan, Italy.
Dean WrightFlorey Institute of Neuroscience and Mental Health, University of Melbourne, Victoria, Australia.
Xing-Ding ZhangDepartment of Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, United States of America.
Constanze SeidenbecherDepartment for Neurochemistry and Molecular Biology, Leibniz Institute for Neurobiology Magdeburg, Magdeburg, Germany. seidenc@lin-magdeburg.de.
Florey Institute of Neuroscience and Mental Health · AULeibniz Institute for Neurobiology · DEUniversity of Melbourne · AUBaylor College of Medicine · USConsejo Nacional de Investigaciones Científicas y Técnicas · ARCross River University of Technology · NGHebrew University of Jerusalem · ILInstitute of Post Graduate Medical Education and Research · INInstituto Politécnico Nacional · MXInstytut Biologii Doświadczalnej im. Marcelego Nenckiego · PLMedway School of Pharmacy · GBNeuroscience Institute · ITPolish Academy of Sciences · PLPompeu Fabra University · ESThe University of Texas MD Anderson Cancer Center · USUConn Health · USUniversidade Federal do Rio de Janeiro · BRUniversity of Copenhagen · DKUniversity of the Witwatersrand · ZAUniversity of Würzburg · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Synapses are essential components of neurons and allow information to travel coordinately throughout the nervous system to adjust behavior to environmental stimuli and to control body functions, memories, and emotions. Thus, optimal synaptic communication is required for proper brain physiology, and slight perturbations of synapse function can lead to brain disorders. In fact, increasing evidence has demonstrated the relevance of synapse dysfunction as a major determinant of many neurological diseases. This notion has led to the concept of synaptopathies as brain diseases with synapse defects as shared pathogenic features. In this review, which was initiated at the 13th International Society for Neurochemistry Advanced School, we discuss basic concepts of synapse structure and function, and provide a critical view of how aberrant synapse physiology may contribute to neurodevelopmental disorders (autism, Down syndrome, startle disease, and epilepsy) as well as neurodegenerative disorders (Alzheimer and Parkinson disease). We finally discuss the appropriateness and potential implications of gathering synapse diseases under a single term. Understanding common causes and intrinsic differences in disease-associated synaptic dysfunction could offer novel clues toward synapse-based therapeutic intervention for neurological and neuropsychiatric disorders. In this Review, which was initiated at the 13th International Society for Neurochemistry (ISN) Advanced School, we discuss basic concepts of synapse structure and function, and provide a critical view of how aberrant synapse physiology may contribute to neurodevelopmental (autism, Down syndrome, startle disease, and epilepsy) as well as neurodegenerative disorders (Alzheimer's and Parkinson's diseases), gathered together under the term of synaptopathies. Read the Editorial Highlight for this article on page 783.

Indexed as

AdultChildHumansNervous System DiseasesNeurodegenerative DiseasesSynapsesAlzheimer diseaseautismDown syndromeepilepsyhyperekplexiasynapses

Identifiers

PMID27333343
PMCPMC5095804
OpenAlexW2460778061

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.